How to Cancel Handbook on Injectable Drugs

Learn how to cancel Handbook on Injectable Drugs subscription on iPhone, Android, Paypal or directly.

Table of Contents:

1. Cancel on iphone
2. Cancel on android
3. Cancel on Paypal
4. Cancel via Email
5. Cancel on Website

Reading time: 41 seconds

Cancel Handbook on Injectable Drugs Subscription on iPhone & iPad

1. On your phone, open "Settings" and tap your Apple ID profile.
2. Click "Subscriptions" and select "Handbook on Injectable Drugs".
3. Click "Cancel Subscription" and confirm the cancellation.

Alternative method via AppStore:

1. Goto the Appstore » your Profile » Subscriptions.
2. select "Handbook on Injectable Drugs" and click "Cancel Subscription".

Cancel Handbook on Injectable Drugs Subscription on Android

1. Launch the PlayStore app and click the hamburger menu icon.
2. Select "Subscriptions" » tap "Handbook on Injectable Drugs" » click "Cancel Subscription".
3. Your subscription to Handbook on Injectable Drugs will now be canceled.

Cancel Handbook on Injectable Drugs Subscription on PayPal

1. Sign in to your PayPal Account and click "Settings ".
2. Select "Payments" and click "Manage Automatic Payments".
3. Under Automatic Payments tab, click "Handbook on Injectable Drugs" or "Skyscape Medpresso Inc" » "Cancel".
4. You are now unsubscribed from Handbook on Injectable Drugs

Cancel Handbook on Injectable Drugs via Email

1. Open your email app
2. Provide all the relevant information regarding your account.
3. Provide a reason for the cancelation.
4. Send the email to support@redacted... Login to see email.

Cancel Subscription Directly on Handbook on Injectable Drugs's Website

1. Visit their website - http://www.skyscape.com/product/handbook-on-injectable-drugs and login to your account.
2. Goto your profile or account page and click "Billings" or "Subscriptions".
3. Click "Cancel" to remove your subscription.

1. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information.. * More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e. g. , Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024. * 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries. * More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e. g. * The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition.

2. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number. * While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers.

3. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.

4. ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly.

5. For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data.

6. Please purchase a yearly auto-renewing subscription to receive content access and available updates.

7. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

8. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”.

9. “Try before you buy" - Download the FREE App, which includes sample content.

10. In-App purchase required to unlock all content.

11. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period.

12. Payment will be charged to your iTunes Account at confirmation of purchase.

13. If you have any questions or comments, email us any time: customersupport@skyscape.